聚焦2026年一季度制药生物工具风险投资趋势(英)-2026。Layering geographic cuts onto this data reveals distinct regional preferences. In Asia, capital-intensive segments drove deal count growth, with services and platforms & reagents posting YoY increases of 45 and 22 deals, respectively. In North America, in silico discovery led with 20 additional deals YoY.
聚焦2026年一季度制药生物工具风险投资趋势(英)-2026。Layering geographic cuts onto this data reveals distinct regional preferences. In Asia, capital-intensive segments drove deal count growth, with services and platforms & reagents posting YoY increases of 45 and 22 deals, respectively. In North America, in silico discovery led with 20 additional deals YoY.
聚焦2026年一季度制药生物工具风险投资趋势(英)-2026。Layering geographic cuts onto this data reveals distinct regional preferences. In Asia, capital-intensive segments drove deal count growth, with services and platforms & reagents posting YoY increases of 45 and 22 deals, respectively. In North America, in silico discovery led with 20 additional deals YoY.
本报告由PitchBook发布,发布于 2026 年。
覆盖 2026 年,全文共 16 页。
本报告为付费报告,可在资料宝站内下单后获取完整内容。
重点分析了制药等议题。